In Agency First, FDA Says Co. Failed To Submit Trial Data
The U.S. Food and Drug Administration said that Acceleron Pharma Inc. is facing possible fines and other penalties if it doesn't properly post the results of a clinical trial that tested...To view the full article, register now.
Already a subscriber? Click here to view full article